Similar articles for PMID: 38038341

Year	Number of Results
2002	1
2004	2
2006	1
2007	1
2009	1
2010	4
2012	1
2013	3
2014	4
2015	6
2016	12
2017	9
2018	10
2019	11
2020	15
2021	10
2022	9
2023	5
2024	0

1

Improving the value of molecular testing: current status and opportunities in colorectal cancer precision medicine.

Li H, Guo L, Wang C, Hu X, Xu Y. Li H, et al. Cancer Biol Med. 2023 Nov 30;21(1):21-8. doi: 10.20892/j.issn.2095-3941.2023.0293. Cancer Biol Med. 2023. PMID: 38038341 Free PMC article. No abstract available.

2

Molecular Biomarkers: A Review of Multiple Applications in Clinical Care of Colorectal Cancer.

Schmitt ML. Schmitt ML. Clin J Oncol Nurs. 2020 Dec 1;24(6):635-643. doi: 10.1188/20.CJON.635-643. Clin J Oncol Nurs. 2020. PMID: 33216064 Review.

3

The changing approach for identifying hereditary colorectal cancer syndromes.

Laghi L, Ricciardiello L. Laghi L, et al. Nat Rev Gastroenterol Hepatol. 2020 Oct;17(10):593-594. doi: 10.1038/s41575-020-0348-y. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32651554 No abstract available.

4

Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.

Molloy MP, Engel A. Molloy MP, et al. Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1179-1181. doi: 10.1080/17474124.2018.1535897. Epub 2018 Oct 17. Expert Rev Gastroenterol Hepatol. 2018. PMID: 30791786 No abstract available.

5

Should next-generation sequencing testing be routinely used in metastatic colorectal cancer?

Dienstmann R, Ciner A, Hochster HS. Dienstmann R, et al. Lancet Oncol. 2018 Nov;19(11):1434-1435. doi: 10.1016/S1470-2045(18)30776-9. Epub 2018 Nov 1. Lancet Oncol. 2018. PMID: 30507475 No abstract available.

6

Reclassifying colorectal cancer subtypes.

Burki TK. Burki TK. Lancet Oncol. 2015 Dec;16(16):e591. doi: 10.1016/S1470-2045(15)00443-X. Epub 2015 Nov 4. Lancet Oncol. 2015. PMID: 26511645 No abstract available.

7

Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer.

Henry JT, Johnson B. Henry JT, et al. Chin Clin Oncol. 2019 Oct;8(5):49. doi: 10.21037/cco.2019.08.08. Epub 2019 Sep 3. Chin Clin Oncol. 2019. PMID: 31500426 Free article. Review.

8

Advances in colorectal cancer genomics and transcriptomics drive early detection and prevention.

Lam KK, Thean LF, Cheah PY. Lam KK, et al. Int J Biochem Cell Biol. 2021 Aug;137:106032. doi: 10.1016/j.biocel.2021.106032. Epub 2021 Jun 25. Int J Biochem Cell Biol. 2021. PMID: 34182137 Review.

9

Biomarkers in Colorectal Cancer.

Yiu AJ, Yiu CY. Yiu AJ, et al. Anticancer Res. 2016 Mar;36(3):1093-102. Anticancer Res. 2016. PMID: 26977004 Review.

10

ICGC-ARGO precision medicine: targeted therapy according to longitudinal assessment of tumour heterogeneity in colorectal cancer.

Kotani D, Nakamura Y, Fujisawa T, Bando H, Sakamoto N, Johns AL, Park K; ICGC-ARGO; Casolino R, Yoshino T, Biankin AV. Kotani D, et al. Lancet Oncol. 2022 Apr;23(4):463-464. doi: 10.1016/S1470-2045(22)00142-5. Lancet Oncol. 2022. PMID: 35358454 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 38038341

94 results

Results by year